O
JBIO

OrbiMed’s Jade Biosciences JBIO Stock Holding History

OrbiMed’s Portfolio JBIO Stock Details JBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.6M Sell
185,011
-346,152
-65% -$5.01M 0.05% 105
2025
Q4 		$8.2M Hold
531,163
– – 0.17% 85
2025
Q3 		$4.58M Hold
531,163
– – 0.11% 87
2025
Q2 		$5.31M Buy
+531,163
New +$18.1M 0.13% 76
2024
Q2 		– Sell
-16,154
Closed -$16.7M – 117
2024
Q1 		$16.7M Sell
16,154
-5,473
-25% -$4.18M 0.31% 71
2023
Q4 		$17.1M Hold
21,627
– – 0.34% 65
2023
Q3 		$10.3M Hold
21,627
– – 0.22% 83
2023
Q2 		$13M Hold
21,627
– – 0.24% 80
2023
Q1 		$15.3M Sell
21,627
-74
-0.3% -$61.4K 0.3% 75
2022
Q4 		$22.3M Sell
21,701
-1,013
-4% -$735K 0.43% 64
2022
Q3 		$13.2K Buy
22,714
+9,040
+66% +$6.03M 0.24% 78
2022
Q2 		$7.48K Sell
13,674
-896
-6% -$428K 0.14% 101
2022
Q1 		$9.35M Sell
14,570
-736
-5% -$286K 0.15% 102
2021
Q4 		$6.32M Hold
15,306
– – 0.08% 128
2021
Q3 		$11.2M Hold
15,306
– – 0.12% 120
2021
Q2 		$12.2M Buy
+15,306
New +$12.2M 0.12% 118

Other funds holding JBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return